<VariationArchive VariationID="3076048" VariationName="NC_000019.10:g.(?_11110652)_(11111639_?)del" VariationType="Deletion" Accession="VCV003076048" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-08" DateCreated="2024-04-20" MostRecentSubmission="2024-04-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3235334" VariationID="3076048">
      <GeneList>
        <Gene Symbol="LDLR" FullName="low density lipoprotein receptor" GeneID="3949" HGNC_ID="HGNC:6547" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="11089463" stop="11133820" display_start="11089463" display_stop="11133820" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="11200037" stop="11244505" display_start="11200037" display_stop="11244505" Strand="+" />
          </Location>
          <OMIM>606945</OMIM>
          <Haploinsufficiency last_evaluated="2021-10-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LDLR">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-10-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LDLR">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NC_000019.10:g.(?_11110652)_(11111639_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>19p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" innerStart="11110652" innerStop="11111639" display_start="11110652" display_stop="11111639" variantLength="988" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.(?_11110652)_(11111639_?)del" Assembly="GRCh38">
            <Expression>NC_000019.10:g.(?_11110652)_(11111639_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000019.10:g.(?_11110652)_(11111639_?)del AND Homozygous familial hypercholesterolemia" Accession="RCV004018366" Version="1">
        <ClassifiedConditionList TraitSetID="48382">
          <ClassifiedCondition DB="MedGen" ID="C0342881">Homozygous familial hypercholesterolemia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-11-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2017-11-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-04-20" MostRecentSubmission="2024-04-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1301956</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20145306</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22698793</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3198114</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9048913</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9254862</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="48382" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="42448" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Familial hypercholesterolemia - homozygous</ElementValue>
                <XRef ID="39140541" DB="NCBI for submitter" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Homozygous familial hypercholesterolemia</ElementValue>
                <XRef ID="MONDO:0018328" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10416" />
                <XRef ID="10416" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Position Statement" Abbrev="CSANZ, 2016">
                <URL>https://www.csanz.edu.au/wp-content/uploads/2017/07/Familial-Hypercholesterolaemia_ratified_-25-Nov-2016.pdf</URL>
                <CitationText>The Cardiac Society of Australia and New Zealand, Diagnosis and Management of Familial Hypercholesterolaemia â€“ Position Statement</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Familial-Hypercholesterolemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, APOB, LDLR, PCSK9 Pathogenic Variants (Familial Hypercholesterolemia), 2019</CitationText>
              </Citation>
              <XRef ID="391665" DB="Orphanet" />
              <XRef ID="C0342881" DB="MedGen" />
              <XRef ID="MONDO:0018328" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9057151" SubmissionDate="2024-04-19" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="84091487|Orphanet:ORPHA391665" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV004848129" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">1301956</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9048913</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20145306</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">3198114</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9254862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22698793</ID>
          </Citation>
          <Comment>The c.941-?_1186+?del variant in LDLR (legacy names: FH Cape Town-2, FH Leuven, and FH Leiden-1) has been reported in &gt;5 individuals with heterozygous familial hypercholesterolemia (FH) and at least 2 individuals with homozygous FH as well as segregated with disease in at least 10 affected relatives from multiple families (Henderson 1988, Peeters 1997, Chae 1997, Chmara 2010, Tichy 2012). It was also absent from large population studies. This variant is reported in ClinVar (Variation IDs: 3701, 441201). This variant is an in-frame deletion of exons 7 and 8, which may result in no protein being produced or a protein product lacking exons 7 and 8. In vitro functional studies provide some evidence that there is residual protein with only 2-5% receptor activity in homozygous cell lines (Hobbs 1992). In summary, this variant meets criteria to be classified as pathogenic for FH in an autosomal dominant manner based upon segregation studies, absence from controls, and functional evidence. ACMG/AMP Criteria applied: PP1_Strong, PM2, PS3_Moderate, PS4_Moderate.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LDLR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000527.5:exon 7</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.10:g.(?_11110652)_(11111639_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA391665" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14389831</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9057151" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA391665" MappingRef="Orphanet">
        <MedGen CUI="C0342881" Name="Homozygous familial hypercholesterolemia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

